Why NovaBay's Stock Is Trading Higher Today

NovaBay Pharmaceuticals, Inc. NBY shares are trading higher after the company announced third-party testing results showing that its Avenova formulation kills SARS-CoV-2. The company intends to submit test results to the EPA for approval.

"Since Avenova's inception, we have known it to be a powerful antimicrobial spray solution, effective against all types of pathogens, including a wide variety of viruses, bacteria, and fungi. Now we have results from a highly reputable independent laboratory confirming Avenova kills the coronavirus that causes COVID-19," said Justin Hall, NovaBay CEO.

Avenova is available without a prescription on Amazon and on Avenova.com.

NovaBay  is a biopharmaceutical company that develops, manufactures, and markets anti-infective products for a multitude of uses.

NovaBay's stock was trading up 62.25% at $1.83 per share on Monday at the time of publication. The company has a 52-week high of $1.94 and a 52-week low of $0.24.

Posted In: BiotechNewsPenny StocksMoversTrading IdeasGeneralwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...